"Leverage the power of the immune system."

Immage Biotherapeutics Corp. develops targeted therapeutics for the treatment of tumors that expresses the MAGE-A antigen. This growing portfolio of treatment targets using one universal vaccine gives the company the advantage of focusing on tumors that have not had viable treatments and yet reduces cost as it is one therapy. Our pipeline is built from a proprietary immunotherapy that can be use alone and in strategic combinations in order to development novel, disease-specific therapies that enhance the body's immune response to treat cancers.